This review is a summary of a recent speaker event featuring Professor Kevin Pile presenting on treatment expectations with rheumatoid arthritis: what is the role of baricitinib?
Professor Kevin Pile is Director of Medicine and Senior Staff Rheumatologist at Campbelltown Hospital, Sydney. He is Conjoint Professor at Western Sydney University and Immediate Past-President of Asia Pacific League of Associations for Rheumatology (APLAR). Primarily a clinician, he works in the public and private, with interests in the pharmacokinetics of febuxostat and the quality of life impact of gout.
Please login below to download this issue (PDF)